De Marinis YZ, Salehi A, Ward CE, Zhang Q, Abdulkader F, Bengtsson M, Braha O, Braun M, Ramracheya R, Amisten S, Habib AM, Moritoh Y, Zang E, Reimann F, Rosengren AH, Shibasaki T, Gribble F, Renstrm E, Seino S, Eliasson L, Rorsman P: GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis
Missing doses during titration may cause temporary appetite rebound, but the medication re-establishes efficacy once regular dosing resumes
Combining the AGT targeting siRNA with an ARB led to a stronger hypotensive effect likely because of the concomitant AT2R stimulation
The aim of this study was to investigate the biomarkers for VPA-induced abnormal liver function in epileptic children and to determine potential mechanisms of its liver injury
Can GLP-1 Affect Sleep Quality and Energy Patterns
GLP-1 MEDICATIONS Access, Affordability, and What Comes Next Federal Developments At the federal level, the White House announced an agreement in November with Eli Lilly and Novo Nordisk to reduce prices and expand Medicare and Medicaid coverage, including lower prices through direct-to-consumer programs